TY - JOUR AU - Cox, H. J. AU - Bhandari, S. AU - Rigby, A. S. AU - Kilpatrick, E. S. PY - 2008 DA - 2008// TI - Mortality at low and high estimated GFR values. A U- shaped curve JO - Nephron Clin Pract VL - 110 UR - https://doi.org/10.1159/000151720 DO - 10.1159/000151720 ID - Cox2008 ER - TY - JOUR AU - Sarnak, M. J. PY - 1998 DA - 1998// TI - Clinical epidemiology of cardiovascular disease in chronic renal disease JO - Am J Kidney Dis VL - 32 UR - https://doi.org/10.1053/ajkd.1998.v32.pm9820470 DO - 10.1053/ajkd.1998.v32.pm9820470 ID - Sarnak1998 ER - TY - JOUR AU - Bhandari, S. AU - Norfolk, D. AU - Brownjohn, A. AU - Turney, J. PY - 1997 DA - 1997// TI - Evaluation of red blood cell ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy JO - Am J Kidney Dis VL - 30 UR - https://doi.org/10.1016/S0272-6386(97)90087-1 DO - 10.1016/S0272-6386(97)90087-1 ID - Bhandari1997 ER - TY - JOUR AU - Besarab, A. AU - Amin, N. AU - Ashan, M. AU - Vogel, S. E. AU - Zazuwa AU - Frinak, S. PY - 2000 DA - 2000// TI - Optimisation of epoetin therapy with intravenous iron supplementation in haemodialysis patients JO - J Am Soc Nephrol VL - 11 ID - Besarab2000 ER - TY - JOUR AU - Bhandari, S. AU - Naudeer, S. PY - 2008 DA - 2008// TI - Improving efficiency and value in Health Care. Intravenous iron management for anaemia associated with chronic kidney disease. Linking treatment to an outpatient clinic, optimising service provision and patient choice JO - J Eval Clin Pract VL - 14 UR - https://doi.org/10.1111/j.1365-2753.2007.00932.x DO - 10.1111/j.1365-2753.2007.00932.x ID - Bhandari2008 ER - TY - JOUR AU - Shah, S. V. AU - Baliga, R. AU - Fonseca, V. A. AU - Rajapurkar, M. PY - 2007 DA - 2007// TI - Oxidants in chronic kidney disease JO - J Am Soc Nephrol VL - 18 UR - https://doi.org/10.1681/ASN.2006050500 DO - 10.1681/ASN.2006050500 ID - Shah2007 ER - TY - JOUR AU - Halliwell, B. AU - Gutteridge, J. M. C. PY - 1990 DA - 1990// TI - Role of free radicals and catalytic metal ions in human disease: an overview JO - Meth Enzymol VL - 186 UR - https://doi.org/10.1016/0076-6879(90)86093-B DO - 10.1016/0076-6879(90)86093-B ID - Halliwell1990 ER - TY - JOUR AU - Rajapurkar, M. M. AU - Baliga, R. AU - Shah, S. V. PY - 2007 DA - 2007// TI - Treatment of patients with glomerulonephritis with an oral iron chelator [abstract] JO - J Am Soc Nephrol VL - 18 ID - Rajapurkar2007 ER - TY - JOUR AU - Lin, J. -. L. AU - Lin-Tan, D. -. T. AU - Hsu, K. -. H. AU - Yu, C. -. C. PY - 2003 DA - 2003// TI - Environmental lead exposure and progression of chronic renal diseases in patients without diabetes JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa021672 DO - 10.1056/NEJMoa021672 ID - Lin2003 ER - TY - JOUR AU - Silverstein, S. B. AU - Rodgers, G. M. PY - 2004 DA - 2004// TI - Parenteral iron preparations JO - Am J Haematol VL - 76 UR - https://doi.org/10.1002/ajh.20056 DO - 10.1002/ajh.20056 ID - Silverstein2004 ER - TY - JOUR AU - Zager, R. A. AU - Johnson, A. C. AU - Hanson, S. Y. AU - Wasse, H. PY - 2002 DA - 2002// TI - Parenteral iron formulations: a comparative toxicological analysis and mechanisms of cell injury JO - Am J Kid Dis VL - 40 UR - https://doi.org/10.1053/ajkd.2002.33917 DO - 10.1053/ajkd.2002.33917 ID - Zager2002 ER - TY - JOUR AU - Zager, R. A. AU - Johnson, A. C. AU - Hanson, S. Y. PY - 2004 DA - 2004// TI - Parenteral iron nephrotoxicity, potential mechanisms and consequences JO - Kidney Int VL - 66 UR - https://doi.org/10.1111/j.1523-1755.2004.00716.x DO - 10.1111/j.1523-1755.2004.00716.x ID - Zager2004 ER - TY - JOUR AU - Jahn, M. R. AU - Andreasen, H. B. AU - Fütterer, S. AU - Nawroth, T. AU - Schünemann, V. AU - Kolb, U. PY - 2011 DA - 2011// TI - A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications JO - Eur J Pharm Biopharm VL - 78 UR - https://doi.org/10.1016/j.ejpb.2011.03.016 DO - 10.1016/j.ejpb.2011.03.016 ID - Jahn2011 ER - TY - JOUR AU - Mori, K. AU - Nakao, K. PY - 2007 DA - 2007// TI - Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage JO - Kidney Int VL - 71 UR - https://doi.org/10.1038/sj.ki.5002165 DO - 10.1038/sj.ki.5002165 ID - Mori2007 ER - TY - JOUR AU - Kjeldsen, L. AU - Johnsen, A. H. AU - Sengelov, H. AU - Borregaard, N. PY - 1993 DA - 1993// TI - Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase JO - J Biol Chem VL - 268 ID - Kjeldsen1993 ER - TY - JOUR AU - Mishra, J. AU - Dent, C. AU - Tarabishi, R. AU - Mitsnefes, M. M. AU - Ma, Q. AU - Kelly, C. PY - 2005 DA - 2005// TI - NGAL as a biomarker of acute renal injury after cardiac surgery JO - Lancet VL - 65 UR - https://doi.org/10.1016/S0140-6736(05)74811-X DO - 10.1016/S0140-6736(05)74811-X ID - Mishra2005 ER - TY - JOUR AU - Bachorzewska-Gajewska, H. AU - Malyszko, J. AU - Sitniewska, E. AU - Malyszko, J. S. AU - Dobrzyckin, S. PY - 2007 DA - 2007// TI - Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography JO - Nephrol Dial Transplant VL - 22 UR - https://doi.org/10.1093/ndt/gfl408 DO - 10.1093/ndt/gfl408 ID - Bachorzewska-Gajewska2007 ER - TY - JOUR AU - Mishra, J. AU - Mori, K. AU - Ma, Q. AU - Kelly, C. AU - Barasch, J. AU - Devarajan, P. PY - 2004 DA - 2004// TI - Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity JO - Am J Nephrol VL - 24 UR - https://doi.org/10.1159/000078452 DO - 10.1159/000078452 ID - Mishra2004 ER - TY - JOUR AU - Mikhail, A. AU - Brown, C. AU - Williams, J. A. AU - Mathrani, V. AU - Shrivastava, R. AU - Evans, J. PY - 2017 DA - 2017// TI - Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease JO - BMC Nephrol VL - 18 UR - https://doi.org/10.1186/s12882-017-0688-1 DO - 10.1186/s12882-017-0688-1 ID - Mikhail2017 ER - TY - JOUR AU - Gandek, B. AU - Sinclair, S. J. AU - Kosinski, M. AU - Ware, J. E. PY - 2004 DA - 2004// TI - Psychometric Evaluation of the SF 36® Health Survey in Medicare Managed Care JO - Health Care Financ Rev VL - 25 ID - Gandek2004 ER - TY - JOUR AU - Broncel, M. AU - Koter-Michalak, M. AU - Chojnowska-Jezierska, J. PY - 2006 DA - 2006// TI - The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia JO - Przeglad Lekarski VL - 63 ID - Broncel2006 ER -